Market cap
$11.9m
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
Revenue rose 20.7% but PBT fell 183.1% and net debt to EBITDA rose to 9.8x, testing balance-sheet flexibility.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$11.9m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
9.15x
Recent market cap compared with trailing earnings.
EPS
0.02
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
2.28x
Enterprise value compared with recent EBITDA.
P/FCF
2.57x
Market cap compared with recent free cash flow.
P/B
0.64x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
HY23 vs HY22
Revenue
$20.7m
Caveat: metric quality flags apply; use this value with basis context.
EBITDA
$1.4m
Caveat: metric quality flags apply; use this value with basis context.
Net profit after tax
−$2.1m
Caveat: metric quality flags apply; use this value with basis context.
Net cash inflow from operating activities
$1.6m
Caveat: metric quality flags apply; use this value with basis context.
Interim dividend per share
−16.0c
— vs —
Profit before tax
−$2.1m
Caveat: metric quality flags apply; use this value with basis context.
Cash and cash equivalents
−$0.09m
-103.5% ↓ vs $2.7m
Total assets
$54.9m
Caveat: metric quality flags apply; use this value with basis context.
Analysis ofSVR HY23Result releasedAnnolyse analysis published
What changed
NPAT moved in lockstep at -$2.1m (-183.1%), so this is not a tax-driven distortion; the loss is being generated at the operating and financing level. Revenue grew 20.7% to $20.7m, within the historical normal range, but EBITDA fell 33.6% to $1.4m and the EBITDA margin of 6.8% is below the historical range (mean 10.0%). Net debt to EBITDA deteriorated to 9.8x from 5.4x as leverage weakened alongside the earnings decline, and equity fell 24.1% to $14.3m.
What matters
First, margin compression is the core economic issue: EBITDA margin at 6.8% versus a historical mean of 10.0% means each dollar of revenue is converting to materially less operating profit, even as top-line growth looks healthy. This matters because revenue growth alone is not evidence of a strengthening business here.
Second, leverage has weakened sharply — net debt to EBITDA of 9.8x versus 5.4x in the prior half, alongside ROE of -14.9% against a historical mean of -3.0%. This reduces financial flexibility and raises the bar for the earnings recovery needed to restore balance-sheet headroom.
Third, cash conversion of 117.3% is above the historical range (mean 38.2%, prior-period range -20.8% to 81.8%), which looks favourable on its face, but capex intensity nearly doubled to 11.4% of revenue from 6.8%, and free cash flow relative to NPAT fell to 34% from 107.1%. The strong operating cash flow figure therefore coexists with continued cash burn once investment spending is included.
Expectations
The prior full-year period was second-half weighted for EBITDA and NPAT (70.5% and 15% of full-year EBITDA and NPAT fell in the first half respectively), so the current half's weak margin and loss do not by themselves confirm a full-year trajectory, but they raise the bar for the second half to deliver a materially stronger result than this period's run rate implies.
Quality of result
Once capex is included, free cash flow relative to NPAT nearly halved to 34% from 107.1%, and capex as a share of revenue rose to 11.4% from 6.8%, indicating that ongoing investment is consuming a rising share of operating cash. Debt was reduced during the period and total liabilities fell modestly, but this occurred against a backdrop of declining equity and rising net debt to EBITDA, so the balance-sheet picture is mixed rather than uniformly improving. The overall quality read is that the operating loss and margin compression are the primary signal, while the strong headline cash-conversion figure is less durable evidence of underlying performance.
Unresolved
This briefing cannot assess forward performance against company-set targets, as no such targets were disclosed in this release.
Chat
Ask follow-up questions about Savor's HY23 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Savor Interim Financial Statements
HY23 / financial reportSavor Interim Results - Appendix 2
HY23 / results announcementSavor Interim Results Announcement
HY23 / results releaseSavor Interim Financial Statements
HY22 / financial reportSavor Interim Results Announcement
HY22 / results announcementSavor Interim Results Announcement
HY22 / results releaseSavor Annual Report 2022
FY22 / financial reportSavor Annual Results - Market Announcement
FY22 / results releaseSavor Annual Results - NZX Appendix 2
FY22 / results announcementSavor 2021 Annual Meeting results
HY22 / commentarySavor 2022 Annual Meeting results
HY23 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Leverage and balance-sheet risk
Net debt / EBITDA is 9.84x, +4.39x versus the prior comparable period.
Cash conversion quality
This result converted 117.3% of EBITDA to operating cash flow, +63.8pp versus the prior comparable period.
Revenue growth context
Revenue growth was 20.7% for this reporting period.
ROE and capital efficiency
ROE was -14.9%, -10.9pp versus the prior comparable period.
Get the next Savor briefing and related NZX reporting-season updates by email.